A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

Weeds in soybean fields are doing more than competing for resources like nutrients and water. More than 100 common weed species are hosts, creating refuge for soybean cyst nematode populations and ...

Scientists at the Free University of Brussels (VUB) have taken a major step forward in pancreatic cancer research. By mapping a healthy pancreas in detail down to the cellular level, they discovered ...

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...

Background A resemblance of pancreatic tumours to their native tissue architecture remains largely unexplored, while it may ...

The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified ...

Sisters with family history among first to test new screening technology designed to detect abnormalities before cancer ...

An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a drug that ...

The mega-threat of the microscopic soybean cyst nematode (SCN) looms large over U.S. soybean fields. SCN’s insatiable appetite for soybean roots makes it the No. 1 yield-reducing soybean pest ...

Chronic pancreatitis is an inflammatory disease and is difficult to manage despite advancements in medical science.

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic cancer Getty Daraxonrasib targets a previously untreatable protein in ...